Skip to content

Bruker BRKR Other Income (Expense)

Other Income (Expense) at other companies

Danaher logo
DanaherDHR
-$73M+7.6%
TEC
Bio-TechneTECH
-$4.27M-884%
WAT
Waters CorporationWAT
$1M0.0%
Agilent Technologies logo
Agilent TechnologiesA
$21M+184%
Illumina logo
IlluminaILMN
-$52M-389%
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$823.4M+2.7%
Gross profit$379.8M-2.9%
Operating income$10.2M-67.9%
Net income$14.4M-17.2%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$137.6M-26.7%
Total debt$1.7B-20.9%
Total equity$2.5B+34.6%
Total assets$6.1B+3.3%

Cash flow

See full
Operating cash flow$71.2M+9.5%
CapEx$24.2M-6.9%
Free cash flow$47.0M+20.5%

Valuation

See full
Market cap$8.71B-13.2%
Enterprise value$10.25B-14.9%
P/S2.5×-0.4×

Profitability

See full
Gross margin45.3%-3.7pp
Operating margin1.3%-5.0pp
Net margin-0.6%-10.0pp
FCF margin1.5%-3.6pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.7×-0.5×
Current ratio1.6×0.0×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Bruker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bruker's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bruker's other income (expense)?
Bruker (BRKR) reported other income (expense) of $11.7M in Q1 2026.
How has Bruker's other income (expense) changed year-over-year?
Bruker's other income (expense) increased by 274.6% year-over-year, from -$6.7M to $11.7M.
What is the long-term trend for Bruker's other income (expense)?
Over 4 years (2021 to 2025), Bruker's other income (expense) has grown at a 23.7% compound annual growth rate (CAGR), from -$19.7M to -$46.2M.
What does other income (expense) mean?
The net result of financial activities not related to core business operations.
How do you interpret other income (expense)?
An increase indicates higher non-operating gains or lower interest costs, while a decrease suggests higher interest expenses or non-operating losses.
How does other income (expense) compare across companies?
Varies widely based on capital structure and debt levels across the life sciences industry.